Nipro Corporation
NPRRF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$219.12B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $219.12 Billion |
|---|---|
| Enterprise Value | $777.25 Billion |
| Annual dividend | $0.20 |
| Dividend yield | 2.31% |
| Earnings per Share | $- |
| Beta | -0.63 |
| Outstanding Shares | - |
Return
| Return on Equity | 4.97% |
|---|---|
| Return on Assets | 1.15% |
| Return on Invested Capital | 4.76% |
Valuation & Multiples
| P/E Ratio | 15.58 |
|---|---|
| PEG | 89.75 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.16 |
| Enterprise Value to EBIT | 20.84 |
| Enterprise Value to Net Income | 55 |
| Total Debt to Enterprise | 0.85 |
| Debt to Equity | 2.34 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 10, 2026
EPS Estimate
$0.09
Consensus analyst estimateRevenue Estimate
$1.05 B
Consensus analyst estimateNext Earnings Call
Expected Date
November 10, 2026
EPS Estimate
$0.14
Consensus analyst estimateRevenue Estimate
$1.05 B
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Nipro Corporation
38,593 employees
CEO: Yoshihiko Sano
Nipro Corporation, along with its affiliated companies, operates across three primary business divisions: medical devices, pharmaceuticals, and pharmaceutical packaging. The company's Medical Device sector is dedicated to the development...